Literature DB >> 6103575

Factors affecting determination of platelet monoamine oxidase activity.

H L Jackman, H Y Meltzer.   

Abstract

Platelet monoamine oxidase (MAO) activity has been reported to be significantly decreased in chronic schizophrenia, but this finding is still quite controversial. Some of the variance between different studies may be due to differences in assay procedures. We have examined the effects of platelet count and platelet pellet protein determinations on assay reliability. The platelet count method was found to be somewhat more reliable than the platelet protein method of determing MAO activity. We also examined the effect of centrifugation conditions on platelet MAO activity. Platelets harvested at 100g had significantly higher MAO activity than platelets harvested at 600g. A significantly greater variation in the 600g platelet MAO activity/100g platelet MAO activity ratio was found in psychiatric patients than in control subjects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6103575     DOI: 10.1093/schbul/6.2.259

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  7 in total

Review 1.  Platelets: A possible glance into brain biological processes in schizophrenia.

Authors:  Eyal Asor; Dorit Ben-Shachar
Journal:  World J Psychiatry       Date:  2012-12-22

2.  Monoamine oxidase gene transcription in human cell lines: treatment with psychoactive drugs and ethanol.

Authors:  J Ekblom; Q S Zhu; K Chen; J C Shih
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  Platelet research in psychiatry.

Authors:  A Wirz-Justice
Journal:  Experientia       Date:  1988-02-15

4.  3H-clonidine and 3H-yohimbine binding to glass fiber filters: implications for studies with platelet membranes.

Authors:  J E Piletz; A C Andorn; A Halaris
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia.

Authors:  J Fang; P H Yu; J W Gorrod; A A Boulton
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

6.  Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment?

Authors:  M Del Vecchio; M Maj; A D'Ambrosio; D Kemali
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?

Authors:  A Fleissner; R Seifert; K Schneider; W Eckert; B Fuisting
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.